Dr. Reddy’s details AGM notice, dividend update

Dr. Reddy’s Laboratories Limited submitted a Form 6-K providing an intimation to multiple stock exchanges about shareholder communications.

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited submitted a Form 6-K providing an intimation to multiple stock exchanges about shareholder communications. The company enclosed copies of newspaper advertisements titled “Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information,” published in Business Standard and Nava Telangana. The same communication was also emailed to all shareholders, ensuring broad circulation of details about the upcoming annual general meeting and related dividend information.

Key Terms

Regulation 47, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, record date, final dividend information, +1 more

5 terms

Regulation 47 regulatory

"Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015"

SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regulatory

"Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015"

record date financial

"Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

final dividend information financial

"Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information"

video conference technical

"Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the main purpose of Dr. Reddy’s (RDY) June 2026 Form 6-K?

The Form 6-K informs exchanges that Dr. Reddy’s shared a newspaper advertisement about its 42nd Annual General Meeting, record date, and final dividend information. It confirms shareholders were formally notified via published notices and email communication.

What shareholder event does Dr. Reddy’s (RDY) reference in this filing?

The filing references Dr. Reddy’s 42nd Annual General Meeting, which will be held through video conference. Details about the meeting, including record date and final dividend information, were provided via a newspaper advertisement sent to shareholders and exchanges.

How did Dr. Reddy’s (RDY) communicate AGM and dividend information to shareholders?

Dr. Reddy’s distributed information through newspaper advertisements in Business Standard and Nava Telangana, titled with AGM, record date, and dividend details. The same communication was also emailed to all shareholders, supporting broad and consistent disclosure across investor channels.

Which exchanges received Dr. Reddy’s (RDY) AGM and dividend intimation?

The intimation was addressed to the National Stock Exchange of India, BSE Limited, the New York Stock Exchange, and NSE IFSC. Each exchange received notice that AGM, record date, and final dividend details were published and circulated to shareholders.

Does this Dr. Reddy’s (RDY) filing specify the final dividend amount or record date?

The filing states that a newspaper advertisement included record date and final dividend information but does not reproduce those figures. Instead, it confirms that such details were published and shared with shareholders and the listed stock exchanges.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 06:27 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

June, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                                         Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                                         No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated June 20, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: June 20, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

June 20, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Newspaper advertisement titled ‘Notice of the 42^nd Annual General Meeting to be held through video conference, record date and final dividend information’

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement titled ‘Notice of the 42^nd Annual General Meeting to be held through video conference, record date and final dividend information’, as published in Business Standard and Nava Telangana.

This communication has also been sent via email to all the shareholders.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99-1 30.2 KB